Essity B, SE0009922164

Essity B stock holds steady as hygiene demand supports earnings

Published on 09/02/2026 at 18:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Essity B stock is trading stable amid solid demand for tissue and hygiene products, with recent quarterly figures showing resilient margins and ongoing cost savings.

Essity AB SE0009922164: SW-Reportage einer Papierfabrik mit großen Rollen
Essity AB (ISIN SE0009922164) zeigt dokumentarisch die industrielle Produktion von Hygienepapier in Schwarzweiß-Optik, Illustration mit AI erstellt.

Essity B stock (ISIN SE0009922164) remains broadly stable as of September 2, 2026, with investors focusing on the Swedish hygiene and health company’s latest earnings and margin trends in tissue and personal care products. The most recent quarterly report highlighted that Essity grew net sales in its core hygiene categories and improved profitability compared with the prior year period, according to market data compiled by financial portals in August 2026. For investors, the combination of steady demand and ongoing efficiency measures is now central to the investment case.

Quarterly figures show margin improvement

In its latest reported quarter, Essity increased net sales versus the same period a year earlier, reflecting continued demand for tissue, baby care, feminine care and incontinence products. According to data from a European stock portal summarizing Essity’s interim results for the first half of 2026, group net sales in that most recent quarter rose by a double-digit percentage compared with the prior year, while adjusted operating profit also increased. The report indicates that Essity’s margin expanded as cost inflation eased and the company’s earlier price increases and productivity measures continued to take effect.

The same overview of Essity’s latest interim report notes that the hygiene and health group’s earnings per share for the latest quarter were higher than in the comparable period of the previous year, supported by stronger operating profit and lower restructuring charges. The improvement in profitability was driven not only by higher volumes in tissue and personal care, but also by ongoing cost savings programs in production and logistics. This means that Essity entered the second half of 2026 with a stronger earnings base than a year earlier, which is an important signal for shareholders who closely watch margin trends in the consumer staples sector.

Focus on cost savings and sustainability

Beyond headline figures, Essity’s latest communication to investors emphasizes continued work on efficiency and sustainable production. According to recent investor information from Essity’s own channels, the company is advancing initiatives to reduce energy use and emissions at its tissue mills, while also implementing automation and digitalization projects to streamline operations. These measures are intended to underpin future margin resilience, particularly in a competitive environment where private-label products compete strongly in tissue and hygiene categories.

Essity also continues to invest in product innovation in its branded portfolio, including premium toilet paper, kitchen towel and incontinence care products. Recent product launches and brand campaigns aim to support pricing power and differentiate Essity’s offerings from lower-priced competitors. For investors, the ability to maintain and selectively raise prices in key markets is crucial, especially as raw material and energy costs can fluctuate. The most recent quarter showed that Essity could sustain higher price levels without significant volume losses, a positive sign for profitability in the 2026 financial year.

Go deeper

More on Essity B fundamentals

Read current news and historical figures for Essity B and follow how the hygiene and health group’s margins and earnings develop over time.

Representative product: tissue and hygiene

Essity generates a large share of its revenue from tissue and hygiene products such as toilet paper, kitchen towels and facial tissues sold under well-known brands in Europe and globally. These everyday consumer products provide a relatively stable demand base, as households continue to purchase them irrespective of economic cycles. In its latest interim report, Essity highlighted that branded tissue products delivered solid volume growth, especially in key European markets, supported by marketing activities and product differentiation. For investors, this segment underpins the group’s recurring cash flow and helps to balance more cyclical areas of the portfolio.

Essity B stock price and investor view

Essity B stock is listed on Nasdaq Stockholm, and as of the latest available closing data around September 1, 2026, the share price reflects a valuation that already prices in improved margins and stable demand for hygiene and health products. The market capitalization, based on this recent closing price, positions Essity among the larger consumer staples companies in the Nordic region. For shareholders, the key question over the coming quarters will be whether the company can continue to grow earnings faster than costs and maintain its dividend while investing in sustainability and innovation.

Essity B key data

  • Company: Essity AB (publ)
  • ISIN: SE0009922164
  • Ticker: ESSITY B
  • Trading venue: Nasdaq Stockholm
  • Sector / Industry: Consumer Staples / Personal Products
  • Index membership: OMX Stockholm indices

Essity B on social media

Disclaimer...

en | SE0009922164 | ESSITY B | boerse | 70045113 | bgmi